Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.

UNLABELLED: Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hb(mass)) and maximal oxygen uptake (v O(2 max)). PURPOSE: This study defined the time course of changes in Hb(mass), v O(2 max) as well as running time trial performance following 4 weeks of rHuEpo administration to d...

Full description

Bibliographic Details
Main Authors: Jérôme Durussel, Evangelia Daskalaki, Martin Anderson, Tushar Chatterji, Diresibachew H Wondimu, Neal Padmanabhan, Rajan K Patel, John D McClure, Yannis P Pitsiladis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3571963?pdf=render